Christine E Cork, PA-C CAQ PSYCH | |
635 Gooseberry Dr Unit 1905, Longmont, CO 80503-6457 | |
(678) 697-9665 | |
Not Available |
Full Name | Christine E Cork |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 635 Gooseberry Dr Unit 1905, Longmont, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811403363 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | PA.0005295 (Colorado) | Secondary |
363A00000X | Physician Assistant | PA.0005295 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christine E Cork, PA-C CAQ PSYCH 635 Gooseberry Dr Unit 1905, Longmont, CO 80503-6457 Ph: (678) 697-9665 | Christine E Cork, PA-C CAQ PSYCH 635 Gooseberry Dr Unit 1905, Longmont, CO 80503-6457 Ph: (678) 697-9665 |
News Archive
Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk. Hypertension will be a key theme at the 65th Annual Conference of the Cardiological Society of India, which takes place during 5-8 December in Bangalore, India, and features a collaborative programme with the European Society of Cardiology.
Senators working feverishly to pass health reform ahead of Congress' August recess raised doubts Wednesday on whether they will be able to pass reform on schedule, The Boston Globe reports.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
Researchers have developed a method to swiftly screen the non-coding DNA of the human genome for links to diseases that are driven by changes in gene regulation.
› Verified 9 days ago